Sign in Subscribe
Attention deficit hyperactivity disorder

Methylphenidate Treatment and Headache Symptoms in ADHD Children

Strategic Insights

— 2 min read

A recent study published in Acta Neurologica Belgica found that methylphenidate treatment did not increase headache risk in children with Attention Deficit Hyperactivity Disorder (ADHD), but its interaction with family history of headache may contribute to migraine-like symptoms. The study, conducted by researchers from the Scientific Institute IRCCS Eugenio Medea, involved 118 children and adolescents with ADHD, with 68 receiving methylphenidate treatment and 50 not receiving pharmacological therapy.

The study aimed to investigate the percentage of headaches in a pediatric ADHD population, comparing children treated with methylphenidate to those not receiving pharmacological therapy, while also considering the potential influence of family history, sex, and age. The study used a retrospective cross-sectional analysis and a structured questionnaire based on international diagnostic criteria to assess headache presence and features. The results showed that headache symptoms were significantly more frequent in participants with a family history of headache, regardless of medication status. However, the combination of methylphenidate treatment and positive family history was significantly associated with migraine-compatible headache presentations.

Key Takeaways:

  • Methylphenidate treatment did not increase headache risk in children with ADHD.
  • Family history of headache should be carefully considered during clinical assessment.
  • The combination of methylphenidate treatment and positive family history was significantly associated with migraine-compatible headache presentations.
  • Headache symptoms were significantly more frequent in participants with a family history of headache, regardless of medication status.
  • The absence of family history was strongly associated with the absence of headache symptoms.
  • Methylphenidate treatment alone did not increase headache risk, but its interaction with familial predisposition may contribute to migraine-like symptoms.
  • The study highlights the importance of considering family history in the clinical assessment of children with ADHD and headache symptoms.
  • The study suggests that methylphenidate treatment may be associated with non-migraine headache presentations in children with ADHD who have a family history of headache.

Statistics:

  • 118 children and adolescents with ADHD participated in the study.
  • 68 children received methylphenidate treatment, while 50 did not receive pharmacological therapy.
  • Headache symptoms were significantly more frequent in participants with a family history of headache, with a frequency of 62.5% versus 30.0% in those without a family history of headache.
  • The combination of methylphenidate treatment and positive family history was associated with migraine-compatible headache presentations in 44.7% of participants.
  • The absence of family history was strongly associated with the absence of headache symptoms, with a frequency of 88.0% versus 56.3% in those with a family history of headache.

Sources:

  • Acta Neurologica Belgica, 2025
  • Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Italy
  • Springer Heidelberg, Tiergartenstrasse 17, D-69121 Heidelberg, Germany (publisher of Acta Neurologica Belgica)
  • Giuseppe Accogli, Scientific Direction, Scientific Institute IRCCS Eugenio Medea, Via Don L. Monza 20, Bosisio Parini, 2384223842, Italy
  • Valentina Nicolardi, Luigi Macchitella, Sara Scoditti, Isabella Fanizza, Anna Maria Spalluto, and Antonio Trabacca (additional authors)
  • NewsRx LLC, 2025
  • Pediatrics Week, November 1, 2025; p 718

Read more